AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net earnings attributable
AbbVie (ABBV) Q4 2022 Earnings: Key financials and quarterly highlights
Categories
Biotechnology
CVS Earnings: CVS Health Q4 2022 profit, revenue increase
CVS Health Corporation (NYSE: CVS) on Wednesday announced financial results for the fourth quarter of 2022, reporting a modest increase in adjusted
Illumina Inc (ILMN) Q4 2022 Earnings Call Transcript
Illumina Inc (NASDAQ:ILMN) Q4 2022 Earnings Call dated Feb. 07, 2023. Corporate Participants: Salli Schwartz -- Vice-President of Investor Relations Francis deSouza -- President and Chief
Vertex Pharmaceuticals Incorporated (VRTX) Q4 2022 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2022 earnings call dated Feb. 07, 2023 Corporate Participants: Susie Lisa -- Senior Vice President, Investor Relations Reshma
Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged 31% year-over-year
Merck (MRK) Earnings: 4Q22 Key Numbers
Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today. Sales increased 2% year-over-year to $13.8 billion. GAAP net income fell 17%
BMY Earnings: Everything you need to know about Bristol Myers’ Q4 results
Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues. The pharma
AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues
Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm's earnings declined. Unadjusted
Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results
Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today. Net sales declined 12% year-over-year to $10.1 billion. Net earnings decreased
Cadrenal Therapeutics downsizes IPO, looks to raise $7 million
There has been an increase in the number of pharma companies taking the IPO route to enhance their research and development activities
WBA Stock: Should you invest in Walgreens Boots Alliance ahead of earnings?
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been a key contributor to the COVID-19 vaccination campaign, supported by its extensive retail network.
Cancer drug maker Felicitex prepares for IPO. Here’s all you need to know
Fewer companies filed for initial public offering this year, compared to 2021 when the market witnessed a record number of IPOs. With
Novavax Inc (NVAX) Q3 2022 Earnings Call Transcript
Novavax Inc (NASDAQ:NVAX) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Silvia Taylor -- Executive Vice President, Chief Communications Officer Stanley C.
Consider these factors before investing in Eli Lilly and Company (LLY)
The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant defying the
Earnings: Highlights of Eli Lilly’s (LLY) Q3 2022 results
Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The company also
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2022 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2022 earnings call dated Oct. 27, 2022 Corporate Participants: Susie Lisa -- Senior Vice President, Investor Relations Reshma
BioMarin Pharmaceutical Inc. (BMRN) Q3 2022 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Traci McCarty -- Vice President of Investor Relations Jean-Jacques
ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while revenues missed.
Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings
Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when the pharmaceutical
BIIB Stock: Is Biogen an investment worth trying now?
Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced competition and
Bristol Myers Squibb (BMY) Earnings: 3Q22 Key Numbers
Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the same period